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Astrocyte dysfunction and inflammation are associ-
ated with the pathogenesis of major depressive
disorder (MDD). However, the mechanisms underly-
ing these effects remain largely unknown. Here, we
found that multiple endocrine neoplasia type 1
(Men1; protein: menin) expression is attenuated in
the brain of mice exposed to CUMS (chronic unpre-
dictable mild stress) or lipopolysaccharide. Astro-
cyte-specific reduction of Men1 (GcKO) led to
depressive-like behaviors in mice. We observed
enhanced NF-kB activation and IL-1b production
with menin deficiency in astrocytes, where depres-
sive-like behaviors in GcKO mice were restored by
NF-kB inhibitor or IL-1b receptor antagonist. Impor-
tantly, we identified a SNP, rs375804228, in human
MEN1, where G503D substitution is associated with
a higher risk of MDD onset. G503D substitution abol-
ished menin-p65 interactions, thereby enhancing
NF-kB activation and IL-1b production. Our results
reveal a distinct astroglial role for menin in regulating
neuroinflammation in depression, indicating that me-
nin may be an attractive therapeutic target in MDD.
INTRODUCTION
Major depressive disorder (MDD) affects approximately 16% of
the population and has become the main cause of disabilityworldwide (CONVERGE consortium, 2015; Ferrari et al., 2013).
Despite the high prevalence of this disorder, mechanisms under-
lying MDD risk remain elusive. MDD is characterized by mood
despondency, disinterest, loss of concentration, and increased
propensity for suicidal thoughts (Canals et al., 2002). MDD was
initially speculated to be a neuropsychiatric disease derived
from neuronal dysfunction (Manji et al., 2001). However,
numerous studies have now implicated astrocyte dysfunction
in the pathogenesis of MDD (Rajkowska and Stockmeier,
2013; Sanacora and Banasr, 2013; Wang et al., 2017). As the
most abundant glial cell type in the mammalian brain, astrocytes
produce pro-inflammatory cytokines such as interleukin (IL)-1b,
which are key to the induction of depressive symptoms in
MDD (Koo and Duman, 2009; Norman et al., 2010). As a pro-in-
flammatory transcriptional activator, nuclear factor-kB (NF-kB) is
a critical regulator of inflammation in the central nervous system
(CNS) (Baltimore, 2011; Oeckinghaus and Ghosh, 2009); how-
ever, the pathogenic driver of NF-kB-dependent pro-inflamma-
tory activation in astrocytes during MDD onset remains unclear.
Recent studies suggest that dysregulation of genes residing
within the chromosome 11q13.1 locus can mediate abnormal
NF-kB activation (Parker et al., 2014). In support of this, chromo-
somal micro-deletion of 11q13.1 was detected in a patient diag-
nosedwithmental retardation (Gimelli et al., 2011). Among the 12
genes deleted in 11q13.1, the multiple endocrine neoplasia type
1 gene (MEN1; encoding the protein menin) was of particular in-
terest. Loss-of-function MEN1 gene mutations are causal to
MEN1 syndrome, which is a dominantly inherited disease char-
acterized by tumor formation in endocrine organs (Matkar
et al., 2013). MEN1 patients also feature neurological irregular-
ities such as depression (Aoki et al., 1997). As a scaffold compo-
nent of nuclear protein complexes, menin has been shown toNeuron 100, 1–13, November 7, 2018 ª 2018 Elsevier Inc. 1
Figure 1. Menin Levels Are Attenuated in Mouse Brain after CUMS and LPS Induction
Male C57BL/6 mice were exposed to chronic unpredictable mild stress (CUMS) or LPS induction.
(A andB) CUMS- (A) and LPS- (B) treatedmice andCtrl mice behaviors in TSTs, FSTs, and SPTs (CUMS, n = 10mice; Ctrl, n = 8mice; LPS treated, n = 9mice; Ctrl,
n = 9 mice).
(C and D) Men1 mRNA and protein levels in CUMS/control (C) and LPS-treated/control (D) mouse brains. n = 3 experimental replicates/group.
(E and F) Cortical sections of CUMS/control (E) or LPS-treated/control (F) mouse brain, stained to visualizemenin (green) with NeuN (red), GFAP (red), or IBA1 (red)
as indicated to characterize menin expression in neurons, astrocytes, or microglia (scale bar, 100 mm). Staining intensity is quantified as shown in the lower
panels.
Data represent mean ± SEM; n.s., not significant; *p < 0.05, **p < 0.01, ***p < 0.001, one-way ANOVA with Turkey’s post hoc test.
See also Figures S1 and S2.
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esis (Heppner et al., 2001; Matkar et al., 2013), potentially
through interactions with the p65 NF-kB subunit (Gang et al.,
2013; Heppner et al., 2001). Although menin is ubiquitously ex-
pressed, its function differs according to tissue and cell type
(Fang et al., 2013; Matkar et al., 2013). However, a function for
menin in the CNS has been largely unexplored.
Here, we provide strong evidence that menin deficiency in-
creases NF-kB-induced IL-1b levels in astroglia to promote
inflammation and associated onset of depressive-like pheno-
types. A SNP associated with MEN1 (rs375804228) is linked to
NF-kB hyper-activation and MDD susceptibility. Together, our
results reveal a distinct role for the tumor suppressor menin in
regulating astroglial inflammation in depressive disorders.2 Neuron 100, 1–13, November 7, 2018RESULTS
Menin Levels Are Attenuated inMouseBrain after CUMS
and LPS Exposure
Chronic stress and neuroinflammation are thought to be funda-
mental in the etiology of MDD. To explore intermediary compo-
nents that are modulated by stress and neuroinflammation, we
exposed male C57BL/6 mice to 6 weeks of chronic unpredict-
able mild stress (CUMS) or 10 days of lipopolysaccharide
(LPS) intraperitoneal injection to mimic depression. Depres-
sive-like phenotypes in these models were validated by tail sus-
pension tests (TSTs) (Can et al., 2012), forced swimming tests
(FSTs) (Chatterjee et al., 2012), and sucrose preference tests
(SPTs) (Figures 1A and 1B). We found that Men1 protein and
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CUMS- and LPS-treated mice by western blotting and RT-PCR
(Figures 1C and 1D). Immunostaining also revealed that menin
is markedly decreased in neurons and astrocytes (arrows) in
mouse brain after CUMS and LPS treatment. Menin expression
was relatively low in microglia (arrows) and little difference in mi-
croglia abundance was observed with CUMS or LPS treatment
(Figures 1E and 1F). The nucleus accumbens (NAc) is an impor-
tant brain region in depression, where menin levels are also
significantly decreased in NAc of CUMS mouse brain (Fig-
ure S1A). These results suggest that menin may be involved in
chronic stress, neuroinflammation, and consequent depres-
sive-like phenotypes.
Generation of Men1 Brain Cell-Type-Specific
Conditional Knockout Mice
Men1 expression can be detected in most mouse organs from
gestational day 7, including the brain (Matkar et al., 2013).
Comparing menin expression in cultured neurons, microglia, as-
trocytes, and oligodendrocytes (Figure S2A), we found that me-
nin expression was relatively high in neurons and astrocytes.
Interestingly, menin expression was most predominant in astro-
cytes (Figures S2B and S2C). By immunostaining, we confirmed
that very little menin can be detected in microglia and oligoden-
drocytes inmouse cortex (Figures 1E, 1F, and S2D).MBP (myelin
basic protein) staining also reveals no difference in myelination
between astrocyte plus neural progenitor cell-specific (GcKO)
and control (Ctrl) mouse cortex and hippocampus (Figure S2E).
To investigate potential astrocyte- or neuron-specific effects
associated with depressive-like phenotypes derived from
Men1 gene deletion, we generated CNS-specific whole-brain
(NcKO), neuron-specific (CcKO), and GcKO Men1 deletion
mouse lines by crossing the floxed Men1 allele with Nestin-
Cre, CamkIIa-cre, or GFAP-Cre transgenic lines (Akbarian
et al., 2002; Scacheri et al., 2004; Tronche et al., 1999; Trumpp
et al., 1999; Westerman et al., 2012), respectively (Figure 2A).
Global Men1 deletion in the CNS resulted in early postnatal
lethality (Zhuang et al., 2018); therefore, we used heterozygous
Men1 deletion strains generated by Nestin-Cre crosses
(Nestin-Cre, Men1f/+) for comparison. Men1 CcKO and GcKO
animals exhibited normal growth rate; body and brain sizes, in
addition to longevity, were indistinguishable from Ctrls (Men1f/f
animals were used as Ctrls) (Figures S3A–S3C) (Zhuang et al.,
2018). To confirm astrocyte-specific menin reduction in GcKO
transgenic animals, we performed menin/glial fibrillary acidic
protein (GFAP) and menin/NeuN double staining in GcKO brain
cortex. GFAP-labeled astrocytes featured attenuated menin
staining, while neuronal menin expression was minimally
affected in GcKO mice compared to Ctrls (Figures S3D–S3F).
No appreciable differences in cortical structure were observed
betweenGcKOandCtrl mice byNissl staining (Figure S3G). Alto-
gether, these findings suggest that postnatal deletion of menin in
brain has minimal effects on overall brain development in mice.
Mice with Astroglial Men1 Reduction Exhibit
Depressive-like Behaviors
We then assessed potential depressive-like behaviors in Men1
NcKO, CcKO, and GcKO mice using TSTs (Can et al., 2012),FSTs (Chatterjee et al., 2012), SPTs, and sucrose consumption
tests (SCTs) (Gross and Pinhasov, 2016). Surprisingly, NcKO
and GcKO mice showed a significant increase in immobility
duration during TSTs and FSTs, whereas CcKO animals
showed little or no variation compared to Ctrls (Figures 2B
and 2C). Furthermore, NcKO and GcKO animals exhibited
less preference to sucrose in SPT and SCT trials, with no effect
observed in CcKO animals (Figures 2D–2F). These results indi-
cate that mice with menin reduction in astrocytes (NcKO and
GcKO lines), but not in neurons (CcKO), manifest depressive-
like phenotypes. Impaired social interactivity is also character-
istically seen in MDD; social interactions in GcKO mice were
also found to be impaired in the presence of novel interaction
partners during social interaction tests (SITs) (Figures 2G
and 2H).
GcKO animals exhibited reduced general locomotion in open
field tests and plus maze assays, with no differences observed
in motor coordination in rotarod tests, and anxiety-like behavior
in open field and elevated plus maze assays (Figures S4A–S4C).
Since reduced locomotor activity may be due to depressive or
motivational deficits in GcKO animals, we performed Morris wa-
ter maze tests to further characterize cognitive behavior. GcKO
mice did not exhibit significant differences in learning and mem-
ory, or swimming speed and distance compared to Ctrl mice
(Figures S4D and S4E), indicating that astroglial reduction of me-
nin had no effect on forced locomotor activity, anxiety, or
learning and memory.
To further determine whether astrocytic menin is critical for
depressive-like behaviors, we used an Fgfr3-iCre(ER) mouse
line in which CreER is expressed from an Fgfr3 promoter and
activation of theCre recombinase is induced by tamoxifin, result-
ing in menin reduction in forebrain subventricular zone progeni-
tor cells and astrocytes (Rivers et al., 2008). Tamoxifin-induced
astrocyte-specific Men1 KO mouse lines were generated by
crossingMen1f/f and Fgfr3-iCre(ER)mouse lines, hereby referred
to as FcKO (Figure 2A). Astroglial menin levels were substantially
decreased in FcKO mice compared to Ctrls with tamoxifin treat-
ment (Figures S3H and S3I), with no significant effects observed
on brain weight (Figure S3J). As expected, FcKO mice also ex-
hibited depressive-like phenotypes as determined by TST and
FST trials (Figure 2I). Together, these results suggest that menin
deficiency in astrocytes promotes depressive-like phenotypes
in mice.
Astrocytic Menin Reduction Promotes IL-1b Production
through NF-kB Activation
To explore molecular mechanisms associated with the pheno-
types observed upon astrocyte Men1 reduction, we examined
mRNA expression profiles by RNA sequencing (RNA-seq)
analysis in primary cultured astrocytes derived from Ctrl and
GcKO mice using a BGISEQ-500 platform. Altogether, 562
genes showed altered expression in 3/3 samples (>2-fold
difference to Ctrls, FDR-corrected p < 0.001; Figure 3A). GO
biological process analysis indicates that cytokine-cytokine
receptor interaction was significantly represented within
the dataset (Figure 3B, RED). This implicates potential modu-
lation of the neuroinflammatory response with astroglial menin
reduction.Neuron 100, 1–13, November 7, 2018 3
Figure 2. Astroglial Men1 Reduction Results in Depressive-like Behavior in Mice
(A) Generation of conditional Men1 knockout mice by crossing Men1f/f lines with Nestin-cre, CamKIIa-cre, GFAP-cre, or Fgfr3-iCre(ER) mouse lines. Resulting
Men1 cKO mouse lines are referred to as NcKO, CcKO, GcKO, or FcKO lines, respectively.
(B and C) Behavioral analysis of NcKO, CcKO, GcKO, and littermate Ctrls using TSTs (B) and FSTs (C).
(D–F) Behavioral analysis of NcKO (D), CcKO (E), GcKO (F), and littermate Ctrls using SPTs and SCTs.
(G and H) Behavioral analysis of GcKO and littermate Ctrls using SITs.
(G) Social affiliation and sociability. Mean duration in the chamber with a novel mouse (‘‘Stranger I’’-containing chamber) compared to the opposite chamber
(‘‘Empty’’ chamber).
(H) Social memory and novelty. Mean duration spent in the chamber with the mouse from the sociability phase (‘‘Stranger I’’), and in the opposite chamber with a
new unfamiliar mouse (‘‘Stranger II’’).
(I) FcKO and littermate Ctrl behaviors in TSTs and FSTs.
Number of mice used in behavior tests: NcKO group, Ctrl, n = 17 mice; NcKO, n = 13 mice; CcKO group, Ctrl, n = 16 mice; CcKO, n = 13 mice; GcKO group, Ctrl,
n = 15 mice; GcKO, n = 12 mice; FcKO group, Ctrl, n = 10 mice; FcKO, n = 10 mice. Data represent mean ± SEM; n.s., not significant; *p < 0.05, **p < 0.01,
***p < 0.001, one-way ANOVA with Tukey’s post hoc analysis.
See also Figures S2–S4.
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depression (Fenn et al., 2014; Skaper et al., 2014). Given that as-
trocytic menin reduction results in depressive-like behaviors, it
seems likely that astroglial neuroinflammatory mechanisms
may drive depressive-like phenotypes in GcKO mice. As pre-
dicted, many pro-inflammatory factors including IL-1b were
significantly upregulated in astrocytes derived from cortex of
GcKO compared to Ctrl mice (Figure 3C). Given that IL-1b is a
key pro-inflammatory cytokine involved in the induction of
depressive-like behaviors (Koo and Duman, 2009; Norman4 Neuron 100, 1–13, November 7, 2018et al., 2010), we confirmed that IL-1b mRNA levels were indeed
dramatically enhanced in cortex of GcKO and NcKO mice, but
not in CcKO mice (Figure 3D). IL-1b mRNA levels were also
enhanced in the NAc of CUMS mouse brain (Figure S1B).
Next, we measured IL-1b levels in cultured primary astrocytes
and neurons derived from cortex inMen1-NcKO mice and litter-
mate Ctrls. In agreement with our results in vivo, we detected
higher basal IL-1b mRNA levels in Ctrl astroglial cultures
compared to Ctrl neuronal cultures (Figure 3E). Neuronal menin
reduction did not affect IL-1b expression in neuronal cultures;
Figure 3. Loss of Menin Enhances IL-1b Production through NF-kB Induction
(A) Differentially expressed genes (DEGs) identified from astrocytes derived from cortex of Ctrl andGcKOmice. Red plots represent upregulatedDEGs. Blue plots
represent downregulated DEGs. Gray points represent non-DEGs. The detailed RNA-seq data have been deposited in the SRA database and can be found at
SRA: SRP151969.
(B) Enriched KEGG pathway in DEGs. The cytokine/cytokine receptor interaction pathway is significantly enriched (red rectangle).
(legend continued on next page)
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inflammation, Neuron (2018), https://doi.org/10.1016/j.neuron.2018.08.031however, menin reduction in astrocytes resulted in an2-fold in-
crease in IL-1b expression (NcKO astrocytes compared to Ctrls;
Figure 3E). Elevations in astroglial IL-1b and reduced menin
levels were further confirmed by measuring IL-1b levels in condi-
tionedmedia fromCtrl andMen1 KO cortical or hippocampal as-
troglial cultures (Figure 3F), as well as cortical brain lysates from
GcKO and Ctrl mice (Figure 3G). Microglia cells are sensitive to
neuroinflammation and are fundamentally involved in the pro-
duction of pro-inflammatory cytokines (Brambilla et al., 2005;
Farina et al., 2007). We observed enhanced activation of micro-
glia in cortex of GcKO mice, with little or no change in prolifera-
tion (Figures S5A and S5B). Thus, microglial activation by astro-
cyte-derived pro-inflammatory cytokines likely exacerbates
neuroinflammation in GcKO mice.
The IL-1b promoter region comprises classical NF-kB bind-
ing sites and has been well characterized as a downstream
NF-kB target (Cogswell et al., 1994). Since astrocytes have
been shown to mediate inflammation through the NF-kB
pathway (Herkenham et al., 2011; Mao et al., 2009), we deter-
mined whether menin reduction can activate NF-kB in astro-
cytes. To test this, we measured NF-kB luciferase reporter
activity in Men1-deficient astrocytes and observed a significant
increase in NF-kB-mediated transactivation (Figure 3H).
Conversely, menin overexpression inMen1-deficient astrocytes
suppressed NF-kB-mediated transactivation (Figure 3H). Using
an astrocytic cell line stably expressing menin (CHG-5-MEN1),
we observed a decrease in IL-1b mRNA and protein levels, with
attenuated NF-kB-mediated transactivation in CHG-5-MEN1
cells compared to CHG-5-vector Ctrls (Figures S6A–S6C).
Similar results were observed in HEK293T cells: while menin
overexpression inhibited NF-kB-mediated transactivation,
MEN1 knockdown enhanced NFkB-mediated transactivation
(Figures S6D–S6F). Additionally, menin overexpression in-
hibited NF-kB-mediated transactivation induced by LPS expo-
sure (Figure S6G), further indicating that menin can suppress
NF-kB-dependent transactivation.
Nuclear p65 translocation can directly enhance NFkB-medi-
ated transactivation. To determine whether menin reduction af-
fects nuclear p65 translocation, we examined changes in p65
distribution by comparing enriched nuclear and cytoplasmic
fractions. No obvious difference in nuclear p65 distribution was
observed in brain cortex comparing GcKO and Ctrl groups (Fig-
ure S6H). Similarly, menin overexpression in CHG-5 cells also(C) Expression of inflammatory cytokines in astrocytes derived from cortex of Gc
(D) qRT-PCR measurements to determine IL-1b expression levels in hippocampa
Ctrls. n = 6 experimental replicates/group.
(E) IL-1b mRNA levels in primary cortical neurons and astrocytes from Ctrl and N
(F and G) IL-1b protein levels in astrocytes derived from cortex and hippocampu
replicates/group.
(H) Astrocytes derived from GcKO or Ctrl mice transfected with GFP or GFP-ME
(I and J) p65 DNA binding capacity was measured by EMSA in HEK293T cells a
shown in (J); n = 3 experimental replicates/group.
(K) Menin/p65 interactions were measured in mouse brain by endogenous co-im
(L) HEK293T cells were co-transfected with p65 together with GFP, GFP-MEN1,
between p65 with menin were determined by coIP; antibodies used in the IP rea
(M) NFkB-mediated transactivation in astrocytes transfected with plasmid const
Data represent mean ± SEM; n.s., not significant; *p < 0.05, **p < 0.01, ***p < 0.0
See also Figure S1, S5, and S6.
6 Neuron 100, 1–13, November 7, 2018had no effect on nuclear p65 distribution (Figure S6I). These re-
sults suggest that menin deficiency does not affect p65 nuclear
translocation.
Next, we determined whether menin directly affects p65/DNA
binding. Significantly, menin overexpression decreased p65
binding activity as determined by electrophoretic mobility shift
assay (EMSA), while Men1 knockdown conversely enhanced
p65/DNA binding interactions (Figures 3I and 3J). Further, me-
nin and p65 was co-immunoprecipitated from mouse brain tis-
sue lysates (Figure 3K), indicating that menin and p65 could
interact within a protein complex. Cytoplasmic menin showed
no effect in inhibiting NF-kB-mediated transactivation; although
cytoplasmic menin constructs (menin fused to a nuclear export
signal, NES) showed interactions with p65, no effects on NF-kB
were observed with these constructs (Figure 3L). In mapping
the regions required for menin/p65 interaction, a 277–541
amino acid region in menin was found to be crucial for p65
binding; menin constructs lacking this region abolished me-
nin-mediated inhibition on NF-kB-dependent transactivation
(Figure 3M). These results suggest that menin suppresses
NF-kB activation through its association with p65, thereby in-
hibiting p65-DNA binding.
NF-kB Inhibitor and IL-1b Receptor Antagonist
Ameliorate Depressive-like Behaviors in GcKO Mice
To determine whether inhibiting the NF-kB/IL-1b pathway can
rescue depressive-like behaviors in GcKO mice, we treated
GcKO and Ctrl mice with an NF-kB inhibitor, pyrrolidine dithio-
carbamate (PDTC), or an IL-1b receptor antagonist (IL-1b-RA)
by intraperitoneal injection for 7 days (Figure 4A). We found
that both PDTC and IL-1b-RA treatment significantly
decreased immobility in GcKO mice in TST and FST trials (Fig-
ures 4B–4E), and rescued SPT and SCT behaviors (Figures 4F
and 4G) in GcKO mice. Further, social interaction deficits were
completely rescued by PDTC administration (Figures 4H and
4I). IL-1b-RA significantly enhanced primary contact with novel
mice, with no effects on a second novel mouse (Figures 4J and
4K). Ctrl mice treated with PDTC or IL-1b-RA did not exhibit
any significant behavioral differences in TST, FST, SIT, SPT,
and SCT trials (Figure 4). These results indicate that PDTC
and IL-1b-RA significantly rescued depressive-like behavioral
deficits in GcKO mice, with little adverse side effects observed
in Ctrls.KO and Ctrl mice.
l samples from 2-month-old NcKO, CcKO, and GcKO mice and their littermate
cKO mice. n = 4 experimental replicates/group.
s (F) or in brain cortex lysates (G) as determined by ELISA. n = 4 experimental
N1; NFkB-mediated transactivation was measured by luciferase assay.
fter transfection with the plasmids indicated. Quantification of panels in (I) are
munoprecipitation (coIP).
GFP-NES, GFP-NES-MEN1, or GFP-MEN1 (277-541) constructs. Interactions
ctions are indicated.
ructs as indicated.
01, one-way ANOVA with Tukey’s post hoc analysis.
Figure 4. NF-kB Inhibitor and IL-1b Receptor Antagonist Ameliorate Depressive-like Behavior in GcKO Mice
(A) Two-month-old GcKO and littermate Ctrl mice treatedwith anNF-kB inhibitor (PDTC) or an IL-1b receptor antagonist (IL-1b-RA) for 7 days, wherebymicewere
subjected to behavioral analysis and following experiments as indicated.
(B–G) Behavioral analysis of PDTC-, IL-1b-RA-, or saline-treated GcKO and littermate Ctrls by TSTs (B and D), FSTs (C and E), SCTs (F), and SPTs (G). Number of
mice used in behavior tests: (B) and (C), control+normal saline group, n = 10 mice; control+NF-kB inhibitor group, n = 6 mice; GcKO+normal saline group, n = 7
mice; GcKO+NF-kB inhibitor group, n = 7mice; (D) and (E), control+normal saline group, n = 11mice; control+IL-1b-R-A group, n = 13mice; GcKO+normal saline
group, n = 6 mice; GcKO+IL-1b-RA group, n = 7 mice; (F) and (G), n = 8 mice for each group.
(H–K) PDTC/saline- (H and I) or IL-1b-RA/saline- (J and K) treated GcKO and littermate Ctrls in social affiliation and sociability assays.
Data represent mean ± SEM; n.s., not significant; *p < 0.05, **p < 0.01, ***p < 0.001, one-way ANOVA with Tukey’s post hoc analysis.
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Abnormalities and Synaptic Deficits Induced by
Astroglial Menin Reduction
Astrocytes provide neurons with morphogenic and metabolic
support and are fundamental to the functional regulation of den-
dritic spines (Allen, 2014). Using a co-culture system comprising
primary Ctrl or Men1 KO astrocytes cultured with Ctrl primary
neurons, we assayed effects of astrocytic menin reduction on
neuronal dendritic morphology, as indicated by microtubule-
associated protein 2 (MAP2) staining (Figure 5A). Interestingly,
dendritic complexity and total length (Figures 5A and 5B) were
reduced in neurons culturedwithMen1KOastrocytes. Ionotropic
glutamate receptorsubunits (GluR1andNR2A)andsynapticcom-
ponents (postsynaptic density protein 95 [PSD95]) were also
dramatically decreased in neurons co-cultured withMen1 KO as-
trocytes (Figures 5C and 5D). Importantly, treatment ofMen1 KO
astrocyte/neuron co-cultures with IL-1b-RA restored neuronal
dendritic complexity, total dendritic length, and synaptic protein
expression (Figures 5A–5D). Further, Golgi staining in GcKOmouse cortex and hippocampus revealed significant attenuation
in dendritic branching, while IL-1b-RA treatment significantly
improved dendritic complexity (Figures 5E and 5F). Expression
ofGluR1,NR2A,PSD95, and IL-1b levelswas also restored in cor-
tex and hippocampus of GcKO mouse brain (Figure S7). Further-
more,microglia activationwasattenuated (FiguresS5CandS5D),
indicating that attenuation of neuroinflammatory response in
GcKObrain is amelioratedwith IL-1b-RA treatment. Further, sero-
tonin levels were markedly decreased in cortex of GcKO mice,
while IL-1b-RA normalized serotonin levels (Figure 5G).
Dendritic arbor and complexity tightly correlate with neuronal
function, and deficits in hippocampal neural plasticity are also
associated with mouse models of depression (Castre´n, 2013;
Christoffel et al., 2011). We compared hippocampal-dependent
long-term potentiation (LTP) in acute brain slices derived from
GcKO and Ctrl mice. Notably, LTP was dramatically impaired
in GcKO mice compared with Ctrls. Moreover, LTP deficiencies
were rescued by exposure to IL-1b-RA in cultured hippocampal
slices by electrophysiological analysis (Figures 5H and 5I).Neuron 100, 1–13, November 7, 2018 7
Figure 5. IL-1b Receptor Antagonist Rescues Morphological Abnormalities and Synaptic Deficits in Neurons Induced by Astrocytic Menin
Reduction
(A and B) WT neurons co-cultured with Ctrl orMen1 KO astrocytes treated with or without IL-1b-RA; neurons were immunostained with an anti-MAP2 antibody.
Representative confocal projection images of dendritic complexity are shown in (A). Scale bar, 20 mm. (B) Quantitation of total dendritic length and dendritic
complexity. n = 20 neurons.
(C and D)Western blot analysis of protein expression in neurons co-cultured withWT orMen1 KO astrocytes treated with or without IL-1b-RA. Immunoblots were
probed with antibodies against the indicated proteins. Quantification of proteins levels is shown in (D); n = 4 experimental replicates/group.
(E and F) Two-month-old GcKO mice treated with IL-1b-RA for 7 days; untreated and IL-1b-RA-treated GcKO and littermate Ctrl lines were subjected to Golgi
staining (threemice were used for every group). Representative Golgi staining from cortex and hippocampal CA1 regions is shown. Scale bar, 10, 100, and 20 mm,
respectively. (F) Quantitation of dendritic complexity in neurons from above mice. n = 20 neurons.
(G) Hippocampal serotonin (5-HT) levels from GcKO or Ctrl mice treated with saline or IL-1b-RA as determined by ELISA. n = 5 experimental replicates/group.
(B–G) Data represent mean ± SEM, *p < 0.05, **p < 0.01, ***p < 0.001, one-way ANOVA with Tukey’s post hoc analysis.
(H and I) LTP recordings from Ctrl and GcKO mouse brain (n = 8 slices from 4 Ctrl mice; 9 slices from 5 CcKO mice; 8 slices from 5 CcKO mice treated with
IL-1b-RA.).
(H) LTP was induced by two trains of 100-Hz stimuli in the Schaffer collaterals.
(I) Significant differences in fEPSP potentiation were determined by comparing fEPSP slopes during last 10 min of recording after high-frequency stimulation.
Data represent mean ± SEM, *p < 0.05, one-way ANOVA with Holm-Sidak pairwise tests.
See also Figures S5 and S7.
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Loss-of-functionMEN1 genemutations are commonly observed
in MEN1 syndrome patients (Chandrasekharappa et al., 1997).
To determine whether MEN1 mutations are associated with the
development of MDD in humans, we genotyped theMEN1 cod-
ing region on chromosome 11q13.1 in a total of 1,032 patients
with MDD and 866 Ctrls. Subjects with MDD and corresponding
Ctrls were age- and sex-matched (Table 1). Within the analyzed
cohort, approximately 18% of the MDD patients reported MDD
in multiple members within their family lineage. In nine SNPs
identified within the MEN1 coding region (Table 2), only one ofTable 1. Clinical Information of Subjects Used in This Study
Case Control
Number of subjects 1,032 866
Sex (male/female) 439/593 381/485
Age (years) 37 ± 13.59 40.86 ± 14.06
Age of onset (years) 34 ± 13.45 N/A
First-episode patients 206 (19.96%) N/A
Family history of MDD 183 (17.73%) N/A
8 Neuron 100, 1–13, November 7, 2018these SNPs (T-allele of rs375804228) was associated with
MDD susceptibility by chi-square test (c2 = 7.236, p = 0.00715,
odds ratio [OR] = 3.208, 95% confidence interval [95% CI],
1.37–7.50). The rs375804228 polymorphism resides on exon
10 in the Men1 locus, and the T-variant of this allele results in a
G503D substitution (Table 2). Two other SNPs, rs2071313 and
rs2959656, are common polymorphisms, with a prevalence of
approximately 20% and 42%, respectively (Concolino et al.,
2016; Lemos and Thakker, 2008) (Table 2). The rs2071313 poly-
morphism resides on exon 9 and is a non-coding variant (D418D)
(Bazzi et al., 2008), while rs2959656 (A/G) results in a benign
amino acid substitution (A541T) (Bazzi et al., 2008).
To investigate the possibility that rs375804228 (G503D) is
involved in MDD, we generated menin GFP-tagged wild-type
(WT) and G503D (GFP-MEN1-G503D) expression vectors. GFP-
MEN1-D418D and GFP-MEN1-A541T constructs were used as
Ctrls. We observed no significant difference in MEN1 mRNA or
protein expression levels in WT- and G503D-menin constructs
(Figures S8A and S8B). Moreover, we observed no difference in
protein stability betweenWT- and G503D-menin using cyclohex-
imide stability assays (Figures S8C and S8D); similar results
were observed in D418D (rs2071313) and A541T (rs2959656)




Substitution Case MAF Control MAF c2 OR 95% CI p
64804659 rs375804228 C/T G503D 0.013 0.004 7.236 3.208 1.37–7.50 0.00715
64804546 rs2959656 A/G A541T 0.244 0.243 4.39E4 1.002 0.85–1.17 0.983
64805130 rs2071313 T/C D418D 0.420 0.421 0.001 0.996 0.81–1.22 0.972
64808033 rs607969 T/C 0.006 0.001 2.575 4.898 0.7–34.1 0.109
64805097 rs376598079 T/A/C 0.001 0 0.985 – – 0.321
64805919 rs577726721 T/G 0 0.003 2.143 – – 0.143
64804600 rs760683615 T/G 0.001 0 0.968 – – 0.325
64804733 rs200280309 G/A 0.001 0.001 0.053 0.795 0.11–5.62 0.818
64806278 rs371364206 T/G 0.001 0 0.935 – – 0.334
m/M, minor allele/major allele; MAF, minor allele frequency. p values were calculated by chi-square test.
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localization (Figure S8E). Together, these results indicate that
rs375804228 (G503D) doesnot alter transcription, protein expres-
sion, protein turnover, or cellular localization profiles in menin.
Since menin associates with p65 to inhibit NF-kB transactiva-
tion, we speculated that G503D may affect menin-p65 associa-
tion. Indeed, MEN1-G503D abolished menin-p65 interaction,
with little or no effect on p65 localization (Figures 6A and S8F).
Furthermore, MEN1-G503D mutation abrogated its ability to
suppress p65-DNA binding interactions (Figure 6B). Although
re-expression of WT-, D418D-, or A541T-menin could restore
NF-kB-mediated transactivation in HEK293T cells transfected
with MEN1-targeting small interfering RNAs, G503D mutation
abolished rescue effects associated with menin re-expression
(Figure 6C). Notably, elevations in NF-kB-mediated transactiva-
tion in Men1-deficient mouse astrocytes derived from cortex
were reduced by MEN1-WT, -D418D, or -A541T expression,
whereas G503D constructs failed to reduce NF-kB hyperactivity
(Figure 6D). Furthermore, in human primary astrocytes, we also
confirm that G503D menin mutant constructs failed to rescue
NF-kB hyper-activation with MEN1 downregulation with
shMEN1 expression (Figure 6E). Finally, elevations in IL-1b
expression from Men1-deficient mouse astrocytes were
reduced by MEN1-WT, -D418D, or -A541T expression; G503D
constructs failed to reduce IL-1b overexpression (Figure 6F).
Altogether, these results implicate a role for G503D MDD menin
variants in abrogating menin-dependent suppression of NF-kB
hyper-activation and pro-inflammatory IL-1b generation.
DISCUSSION
Neuroinflammation (Maes, 1994; M€uller, 2014) and pathological
alterations in astrocytic function (Slavich and Irwin, 2014; Wang
et al., 2017) have been previously reported in depressive disor-
ders. As the most abundant cell type in the brain, astrocytes
play a central role inmediating and regulating neuroinflammation
(Farina et al., 2007). However, molecular and cellular mecha-
nisms underlying the regulation of astrocyte-mediated neuroin-
flammation in depression remain elusive. Here, we demonstrate
that reduction of menin in astrocytes leads to a depressive-like
phenotype, including despondent mood and social interactivitydeficits. Increased neuroinflammation drives behavioral abnor-
malities in astroglialMen1-deficient mice. In addition, we identi-
fied a MEN1 SNP, rs375804228, that is associated with an
elevated risk of MDD onset and leads to aberrant NF-kB activa-
tion and IL-1b production.
Microglia andastrocytesmediate theproduction of pro-inflam-
matory cytokines (Brambilla et al., 2005; Farina et al., 2007),
which drives the pathogenesis of depressive-like phenotypes
(Fenn et al., 2014; Skaper et al., 2014). In the CNS, astrocytes
represent the most abundant cell type in the brain and feature
prominent NF-kB activity (Herkenham et al., 2011; Yang et al.,
2009). Activation of NF-kB is a common feature inMDDand other
neurological conditions (Caviedes et al., 2017), whereas
NF-kB hyperactivity leads to the production of pro-inflammatory
cytokines such as IL-1b, which is a key driver in the clinical
manifestation of depressive symptoms. In addition to astrocytes,
NF-kB is also expressed in microglia. Although our data directly
indicate that NF-kB-mediated neuroinflammation in astrocytes
results in depressive-like phenotypes, microglia may also simi-
larly modulate neuroinflammation through NF-kB induction.
Since menin levels are relatively low in microglia, the NF-kB
pathway may be more sensitive to activation in microglia
through menin-independent pathways. Furthermore, menin-
deficient astrocyte-derived pro-inflammatory factors also induce
microglial activation, thereby leading to neuronal dysfunction
through numerous microglial-derived factors. Further, the sum
of our results indicates that astrocyte-specific Men1 deletion
may be a useful model to study neuroinflammatory disorders.
Biological pathwaysmediatedbypro-inflammatory cytokines in
the pathogenesis of depression disorders include HPA (hypotha-
lamic-pituitary-adrenal) axis dysfunction (Belvederi Murri et al.,
2014; Krishnan andNestler, 2008), reduced serotonin levels (Frodl
et al., 2010; Gatt et al., 2009), and impaired neuroplasticity (Eyre
and Baune, 2012; Yirmiya and Goshen, 2011). Glucocorticoids
are generated, regulated, and secreted by the HPA axis, and are
elevated in serum from patients suffering from depression (Parker
et al., 2003; Raison and Miller, 2003). Further, serotonin levels
were markedly decreased in Men1-deficient GcKO mice, while
IL-1b-RA normalized serotonin levels (Figure 5G). Together, these
results give strong indication that astrocytic menin can alter sero-
tonin levels,whichcanhaveavisible impactonclinicaldepression.Neuron 100, 1–13, November 7, 2018 9
Figure 6. MDD-Associated G503D Menin Mutation Abrogates Menin/p65 Interactions and Menin-Dependent NF-kB Suppression
(A) Interactions between p65 and WT menin or relevant menin mutations were determined in HEK293T cells by co-transfection with p65 and GFP Ctrl,
GFP-MEN1, GFP-MEN1-D418D, GFP-MEN1-G503D, or GFP-MEN1-A541T constructs. n = 3 experimental replicates/group. Quantification of p65/menin
coprecipitation is presented in the graph below.
(B) p65 DNA binding activity measured by EMSA in HEK293T cells following transfection with the plasmids as indicated. n = 3 experimental replicates/group.
Quantification is presented in the graph below.
(C) NFkB-mediated transactivation in HEK293T cells following transfection with plasmid vectors as indicated. n = 3 experimental replicates/group.
(D) NFkB-mediated transactivation in Ctrl or Men1-deficient astrocytes derived from mouse cortex transfected with vectors as indicated. n = 3 experimental
replicates/group.
(E) NFkB-mediated transactivation in human primary astrocytes transfected with vectors as indicated. n = 3 experimental replicates/group.
(F) IL-1b levels in astrocytes derived from mouse cortex transfected with the vectors indicated as determined by ELISA. n = 4 experimental replicates/group.
Data represent mean ± SEM; n.s., not significant; *p < 0.05, **p < 0.01, ***p < 0.001, one-way ANOVA with Tukey’s post hoc analysis.
See also Figure S8.
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neuronal dysfunction (Manji et al., 2001). Indeed, depression
has been shown to be induced by dysregulated mechanisms
that influence synaptic plasticity in afflicted regions (Duman
and Aghajanian, 2012). Neuronal impairment in depression is
associated with reduced dendritic complexity and spine num-
ber, as observed in postmortem brain samples from patients
with depressive disorder and rodent stressmodels of depression
(Rajkowska et al., 1999; Stockmeier et al., 2004). We observed a
substantial decrease in dendritic complexity in the cortex and
hippocampus of GcKO mice.
Although our study mainly concentrated on the two major
brain areas of cortex and hippocampus, other brain regions
are also associated with depression. The NAc plays key roles
in depression symptomatology including anhedonia and
reduced motivation (Lim et al., 2012; Stuber et al., 2011). We
also observed that menin mRNA levels were markedly
decreased in NAc of CUMS mouse brain, while IL-1b levels
increased dramatically in NAc of GcKO mice (Figure S1). Since
menin is expressed throughout the entire brain, the effect
of menin on neuroinflammation in other brain regions warrants
further investigation. Given that our results show that IL-1b-RA10 Neuron 100, 1–13, November 7, 2018can restore morphogenic deficits and hippocampal LTP impair-
ment, NF-kB inhibitors and IL-1b-RA may represent potential
treatment strategies to ameliorate inflammation-based depres-
sion disorders.
Etiologically, MDD is a complex disease that involves a com-
bination of environmental and genetic factors (Bosker et al.,
2011). Cumulative evidence indicates that heritable genetic fac-
tors are associated with MDD (Hyde et al., 2016; Wray et al.,
2012). Numerous candidate genes have been characterized in
association with depression (Hyde et al., 2016) and functional
links between depression and genes regulating the serotonin
or neurotrophin signaling have been implicated (Lo´pez-Leo´n
et al., 2008; Nugent et al., 2011). Despite strong evidence sup-
porting the involvement of heritable components in MDD, ef-
forts to clarify biological mechanisms through common or
rare variant association studies have been unsuccessful. This
has been attributed to heterogeneity of the disease and
absence of established standards in clinical diagnosis.
Recently, genome-wide association studies have implicated
several SNPs associated with major depression (Hek et al.,
2013; Lewis et al., 2010; Nugent et al., 2011; Sullivan et al.,
2009). The human MEN1 gene is located at the 11q13.1 locus,
Please cite this article in press as: Leng et al., Menin Deficiency Leads to Depressive-like Behaviors in Mice by Modulating Astrocyte-Mediated Neuro-
inflammation, Neuron (2018), https://doi.org/10.1016/j.neuron.2018.08.031and MEN1 gene mutations that normally inactivate this gene
are commonly found in patients with MEN1 syndrome (Chan-
drasekharappa et al., 1997; Lemmens et al., 1997). To date,
approximately 1,500 MEN1 mutations have been reported in
patients with endocrine disorders (Concolino et al., 2016; Le-
mos and Thakker, 2008); here, our results indicate that carriers
of the MEN1 SNP rs375804228 G503D risk variant are associ-
ated with a higher risk of MDD onset. This is the first MEN1
gene mutation characterized outside of MEN1 syndrome and
is unique among all MEN1 gene mutations reported previously.
The majority of MDD patients are heterozygous carriers for the
rs375804228 SNP and would therefore be predicted to mani-
fest a partial loss of menin function, thereby triggering conse-
quent NF-kB activation/inflammation in depressive onset. Our
findings linking this menin-associated SNP to MDD could be
utilized in early diagnosis of depression through diagnostic
screening and implicate potential attenuation of the NF-kB
pathway in personalized treatment strategies in patients diag-
nosed with menin-associated MDD. Our data also indicate
that MEN1 syndrome patients with MEN1 mutations may also
be at risk for MDD; future studies may indicate whether muta-
tions associated with MEN1 syndrome can also affect
MDD onset.
In summary, we have identified a distinct role for astrocytic
menin in the onset of depression through neuroinflammatory
pathways. These results also suggest that menin could also be
a prognostic marker for depression disorders, whichmay be pre-
dictive of depressive symptoms and oncogenic potential.STAR+METHODS
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Human Subjects
A total of 1032 unrelated patients with MDD (439 males and 593 females) were recruited from the Department of Psychiatry, First
Hospital of Shanxi Medical University, Taiyuan, China; at time period between January 2006 and December 2013. Clinical diagnosis
was assessed by aminimumof two psychiatrists according to criteria established by the ‘‘Diagnostic and Statistical Manual ofMental
Disorders Fourth Edition (DSM-IV)’’ for major depressive disorders. Cases comprised an age range of 37.0 ± 13.59 (SD) years, and
experienced at least one episode of MDD within established DSM-IV clinical criteria. Criteria to exclude patients within our analyses
include pre-existing history of bipolar disorder, mental retardation, psychosis, severe medical conditions, pregnancy, abnormal lab-
oratory baseline values, and/or a history of alcoholism or drug abuse. Meanwhile, 866 unrelated healthy subjects (381males and 485
females), were also recruited as controls. Controls were recruited from local communities and information was disclosed regarding
medical and family history. Controls comprised ages ranging 40.86 ± 14.06 (SD) years. Criteria to exclude patients within the control
group include a history of major psychiatric or neurological disorders, psychiatric treatment or drug abuse, and/or family history
of inherited severe psychiatric disorder. MDD and control subjects were respectively stratified into six subsets according to their
age (< 21; 21-30, 31-40, 41-50, 51-60 and > 60). 40% of the individuals were randomly sampled from each subset for analysis. All
the subjects were of Chinese Han origin, and originated from Northern China. Detailed clinical information regarding the patients
and controls are presented in Table 1. Written informed consents were obtained from all patients and controls in this study, and
approved by the Ethics Committee of Chinese Academy of Medical Sciences and Peking Union Medical College (014-2016).
Animals
All mice were maintained in the core animal facility at Xiamen University, and all experimental procedures involved were performed
according to protocols approved by the Institutional Animal Care and Use Committee at Xiamen University.
Mice were housed under a 12 h light/dark cycle with free access to standard rodent chow and water. Each cage housed a
maximum of four mice. Mice were maintained under Specific-Pathogen-Free (SPF) conditions and were not subject to immunosup-
pression. Health of the animals used was regularly controlled by animal caretakers. All mice used in the study were not previously
involved in other experimental procedures, and were free from other non-relevant exposure to drugs or tests. A mixture of 2 month
old litter/age-matchedmale and femalemicewere employed in all studies and no differences between sexeswere observed. Animals
were used according to ‘‘3Rs’’ principles (Replacement, Reduction and Refinement) in all experimental procedures. In some
experiments, animals were subjected to two experimental conditions with a single control group (Figures 4F and 4G) to minimize
the number of animals used.
The floxed Men1 mouse strain was obtained from Dr. Guanghui Jin and Dr. Xianxin Hua (Crabtree et al., 2003). Nestin-Cre,
CamkIIa-cre, GFAP-Cre and Fgfr3-iCre(ER) transgenic mice (Scacheri et al., 2004; Tronche et al., 1999; Trumpp et al., 1999; West-
erman et al., 2012) were obtained fromDr. Jiawei Zhou at the Institute of Neuroscience, Chinese Academy of Science; thesemice are
available from Jackson Laboratory. Men1-NcKO, CcKO, GcKO and FcKO mice were obtained by crossing Men1 floxed mice with
respective Nestin-Cre, CamkIIa-cre, GFAP-Cre or Fgfr3-iCre(ER) mouse lines. Men1 floxed mice were used as controls. FcKO or
control mice were treated with tamoxifin at 0.2 mg/g body weight or vehicle control by oral gavage once a day for five consecutive
days. Tamoxifin was dissolved in 5% ethanol/corn oil at a final concentration of 50 mg/mL.
Chronic Unpredictable Mild Stress (CUMS): C57BL/6 male wild-type mice were divided into control and CUMS groups. CUMS
mice were maintained in individual cages. CUMS involved exposure to a variety of mild stressors: (i) 24h food deprivation, (ii) 24h
water deprivation, (iii) 1h of exposure to an empty bottle, (iv) 7h cage tilt (45), (v) overnight illumination, (vi) 24h habitation in a soiledNeuron 100, 1–13.e1–e7, November 7, 2018 e2
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exposure to a foreign object (e.g., a piece of plastic). These stressors were randomly scheduled over a 3 week period.
LPS-induced mouse model: Male C57BL6/J mice (2 months) were intraperitoneally injected with LPS (Sigma, L-2880) dissolved in
sterile 0.9% saline at 0.5mg/kg. This dosage was used to stimulate infection without inducing obvious inflammation or other mala-
dies. Saline or LPS injection was administered between 09:00 and 09:30 a.m. daily for 10 days. Behavioral tests were performed 24




All experiments described in this studywere performed aminimumof 3 times.We did not use a statistical method to predetermine the
proper sample size. The sample size per experiment was determined according to previous publications. All the experiments
involving cKOmice and relevant rescue experiments were performed and analyzed in a blind manner. Specifically, mouse genotype
was de-identified during the experimental trials in the behavioral analyses described. Similarly, mice subjected to electrophysiolog-
ical analysis (LTP) were identified by number where the genotype was withheld during electrophysiological recording. In our image
analysis for neuronal morphology, images were acquired and genotype/treatment was de-identified in the image files for analysis.
Drug Administration
IL-1b-RA (BBI Life Sciences #RC003) was dissolved in aCSF and applied to slice preparations for electrophysiological analysis by
perfusion at a final concentration of 200 mg/ml. For behavioral analysis, PDTC and IL-1b-RA were dissolved in 0.9% NaCl and admin-
istered intraperitoneally at 50 mg/kg and 50 pg/kg, respectively.
Neuron, Astrocyte, Microglia, Oligodendrocyte and Tissue culture procedures
Primary neurons were dissected from timed-pregnant females at E16.5. Briefly, brain cortices were dissected from pups of varying
genotypes. The meninges were removed, and cortical tissue was dissociated by enzymatic digestion. Isolated primary neurons were
plated on poly-D-lysine coated dishes, and cultured in Neurobasal medium supplemented with B27 (GIBCO)/1% penicillin/strepto-
mycin (Invitrogen) and maintained in a 5% CO2 incubator at 37
C.
Primary astrocyteswere cultured in astroglial medium (Dulbecco’smodified eaglemedium/Nutrient mixture F-12 (DMEM/F12) (1:1)
(GIBCO) with 10% fetal bovine serum (FBS). Contaminating cells in the astroglia monolayer were removed by overnight shaking at
220 rpm at 37C. For co-culture experiments, astroglial cells were seeded on matrigel-coated cell culture inserts (Costar, #3450,
#3470) and transferred to DIV1 primary neurons. 5 mM AraC was supplemented to reduce glial proliferation. Co-cultures were main-
tained for 10 days before immunostaining or western blotting. Three independent cultures were generated and analyzed for all ex-
periments. Human primary astrocytes were purchased from ScienCell (HA1800) and cultured in Astrocyte Medium (ScienCell,
#1801). Human astrocytes were electroporated using a Lonza nucleofector with an Amaxa Basic Nucleofector Kit according to
the manufacturer’s instructions.
Primary microglial cultures were obtained by microdissection from brains of <2-day-old neonatal C57BL/6J mice. After removing
the meninges, brains were mechanically minced and dissociated with 0.25% trypsin. After trypsin inactivation, the tissue suspension
was passed through a 70 mm nylon cell strainer. Cell pellets were harvested and resuspended in DMEM supplemented with 10%
heat-inactivated FBS and plated on poly-L-lysine pre-coated culture flasks. After 3 days, medium was changed, containing
25 ng/mL GM-CSF and 10% FBS. Primary microglial cells were harvested by shaking (200 rpm, 20 min) after 10-12d in culture,
and every 3 days thereafter.
Mouse oligodendrocyte precursor cells (OPCs) were isolated from P4 to P7 mouse brain cortices. Briefly, dissociated mouse
cortices were resuspended in panning buffer. The cells were incubated on panning plates coated with an anti-GalC antibody for
30min to depletemature oligodendrocytes, and subsequently incubated for 45min onpanningplates coatedwith ananti-O4 antibody
to collect OPCs. Adherent cells were trypsinized and seeded onto poly-D-lysine-coated plates. Cells were grown in serum-freemedia
with 2%B-27, 1%N2, PDGF-AA (20 ng/mL), bFGF (20 ng/mL), CNTF (10 ng/mL) and NT3 (1 ng/mL). OPC differentiation was induced
by the removal of PDGF-AA, bFGF and NT3 from the growth media, and triiodothyronine (T3) (60 nM) was added to the cultures.
HEK293T, CHG5-MEN1 andCHGcell lines were cultured in DMEMsupplementedwith 10%FBS andmaintained at 37C in humid-
ified air containing 5% CO2. A stable menin-overexpressing cell line CHG5-MEN1 was established in a CHG human glioma cell line.
Western blotting
Cultured cells and mouse brain tissues (include cortex and hippocampus) were homogenized in lysis buffer (RIPA) on ice for 40 min,
and subsequently centrifuged at 12,000 rpm for 10 min at 4C. Supernatants were transferred to a clean 1.5ml tube and protein sam-
ples were resolved by SDS-PAGE (sodium dodecyl sulfate–polyacrylamide gel electrophoresis) and subsequent immunoblotted onto
PVDF membranes. Sample containing 30 mg of protein was separated using 10% SDS-PAGE gels. Proteins were transferred onto
PVDF (polyvinylidene difluoride) membranes in an ice cold buffer (25mM Tris HCl, 192mM glycine, and 20% methanol) by electro-
transfer for 1.5 h. Immunoblots were probed with indicated antibodies. Goat-anti-mouse secondary antibodies and goat-anti-rabbite3 Neuron 100, 1–13.e1–e7, November 7, 2018
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b-actin or GAPDH (in total protein or cytoplasmic extract) or hnRNP (for nuclear extracts), and averaged from at least three indepen-
dent experiments.
Quantitative RT-PCR
Total RNA from animal tissues and cells were isolated using Trizol reagent according to the manufacturer’s instructions (Invitrogen).
Reverse transcription was performed using ReverTra Ace qPCR RT Master Mix (Toyobo, FSQ-201). RNA concentrations were
adjusted to 1.2 mg/mL in nuclease-free water, and total RNA was reverse-transcribed in a 20 mL reaction volume. cDNAwas amplified
by real-time quantitative RT-PCR using SYBR Green (Roche) reagent. Samples were assayed in triplicate and GAPDH was used as





















plk0.1 MEN1 shRNA and pcDNA3.1 MEN1 were kindly provided by Dr. Guanghui Jin (Canaff et al., 2012). GFP-MEN1 and GFP-
MEN1(277-541) were generated by inserting target genes or gene fragments amplified by PCR into the pEGFP-C3 vector
(Clonetech). GFP-NES-MEN1 was generated by inserting MEN1 into a GFP-NES vector. GFP-MEN1 (D418D), GFP-MEN1
(A541T), and GFP-MEN1 (G503D) mutations were generated by site-directed mutagenesis (Stratagene); Primer sequences used
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follows: 50-TGCTCCGACTCTTATCTGTGTTCAAGAGACACAGATAAGAGTCGGAGCTTTTTTC-30;30-TCGAGAAAAAAGCTCCGACT
CTTATCTGTGTCTCTTGAACACAGATAAGAGTCGGAGCA-50.
NF-kB promoter-luciferase reporter assay
The NF-kB promoter-luciferase vector was generated by inserting a 100-bp fragment comprising the mouse NF-kB promoter region
into a pGM-lu vector. Astrocytes or HEK293T cells were transfected with the NF-kB promoter-luciferase vector together with dual
reporter plasmid pRL-TK using Lipofectamine LTX and Plus Reagent (Invitrogen). Cell lysates were generated using a passive lysis
buffer (PLB) (Promega). Firefly and Renilla luciferase activity was measured in cell lysates according to the manufacturer’s instruc-
tions using a Dual Luciferase Assay System with a Turner TD-20/20 luminometer (Turner Designs, Sunnyvale, CA, USA). Relative
firefly luciferase activity was calculated by normalizing transfection efficiency to Renilla luciferase activity. The mouse NF-kB pro-
moter region comprised the following sequence: GGCCTAACTGGCCGGTACCGCTAGCCTCGATGGGAATTTCCGGGAATTTCCGG
GAATTTCCGGAATTTCCGCGCGTAGATCTGCAGAAGCTTAGACACT
Golgi staining
Golgi staining was performed using the FD Rapid Golgi Stain kit according to the manufacturer’s instructions (FD Neuro Technolo-
gies). Freshly dissected brains were immersed in the impregnation solution, comprising equal volumes of Solutions A and B, and
stored at room temperature for 2 weeks in the dark. Then brains were transferred into Solution C and stored at 4C in the dark for
at least 48 hours. Brains were then sectioned using a vibratome (Leica 1200S) at a thickness of 200 mm. Brain sections were then
stained with Solutions D and E. Golgi-stained neurons and dendritic segments from cortex and hippocampus were imaged by
microscopy. Dendritic branching and spines were analyzed using NIH ImageJ software.
Co-immunoprecipitation
Brain or cell lysates were pre-cleared with protein A-Sepharose beads. Menin or GFP proteins were precipitated by adding anti-
menin or GFP antibodies. After incubation for 2 hours at 4C, complexes were precipitated with 10 mL of protein A-Sepharose beads
with gentle agitation at 4C for 4 hours; nonspecific IgG was used as a negative control. Beads were washed, and the immunopre-
cipitated protein complex was loaded onto a 12% SDS-PAGE gel and processed for western blotting.
Enzyme Linked Immunosorbent Assay (ELISA)
IL-1b, Cortisol and Serotonin (5-HT) levels in cell culture supernatant, serum or tissues were measured using mouse IL-1b, Cortisol
and 5-HT ELISA Kits (R&D-Valukine Elisa Kit, Cat: VAL601; R&D-Parameter Elisa Kit, Cat: KGE008B; Shanghai Meilian, mouse 5-HT
Elisa kit, Cat: M1001891) according to the manufacturer’s instructions.
Electrophoretic Mobility Shift Assay (EMSA)
EMSA reactions comprised 1ng of a 50-labeled DNA probe, 12.5 ng/ml of an equimolar mix of Poly (dI-dC) and Poly (dA-dT) non-spe-
cific DNA competitor and lysates from cells transfected with various vector constructs. Reactions were incubated at 37C for 20 min
and separated on 6% acrylamide–bisacrylamide non-denaturing gels using 0.5 3 Tris–borate–EDTA buffer, pH 8.3 (TBE). Samples
were subjected to electrophoresis for 2 hours at 100V using ice-cold 0.5 3 TBE buffer, and DNA was transferred onto Hybond-N+
membranes (GE Healthcare) by blotting at 250 mA for 60 min using a semidry transfer unit, followed by UV cross-linking. The biotin-
labeled DNA was visualized using a Phototope-Star detection kit (Thermo, USA).
Immunofluorescence
Mouse brain sections or cultured cells were washed three times with PBS and antigen retrieval was performed using citrate buffer
(pH 7.0); samples were then permeabilized and blocked in PBS containing 0.5% Triton X-100 and 10% normal goat serum at room
temperature for 1 h. Sections were incubated with primary antibodies in blocking buffer overnight at 4C. After washing, secondary
antibodies were added to the blocking buffer and incubated for one hour. Samples were thenwashed, and counterstainedwith DAPI.
Images were acquired using a Nikon confocal microscope.
Primary antibodies used for immunostaining include: menin (rabbit, 1:1000; Abcam, Ab4452), p65 (rabbit, 1:1000; Cell Signaling
Technology, #8242), GFAP (mouse, 1:500; Cell Signaling Technology, #3670), NeuN (mouse, 1:1000; Millipore, #MAB377), Iba1
(Mouse, 1:300; Santa cruz, Sc-32725), CC1 (mouse, 1:500; Millipore, #OP80), PDGFRa (mouse, 1:500; R&D, #AF1062), MBP (rabbit,
1:500; Santa Cruz, #Sc13914), GFAP (goat, 1:500; Santa Cruz, #Sc6170). 488/594 donkey anti-mouse/rabbit secondary antibodies
(1:1000) and Mounting Medium with DAPI was purchased from Invitrogen.
Protein stability assays
GFP-tagged MEN1 or MEN1 mutation constructs were transfected into HEK293T cells treated with cycloheximide (CHX) at
200 mg/mL at different time points. Proteins were extracted and subjected to western blotting; GFP-tagged menin proteins were
detected using an anti-GFP antibody. Turnover of WT-menin/menin variants was quantified using ImageJ.e5 Neuron 100, 1–13.e1–e7, November 7, 2018
Please cite this article in press as: Leng et al., Menin Deficiency Leads to Depressive-like Behaviors in Mice by Modulating Astrocyte-Mediated Neuro-
inflammation, Neuron (2018), https://doi.org/10.1016/j.neuron.2018.08.031Electrophysiology
For hippocampal slice recordings, 400 mm horizontal slices from control and GcKO mice were prepared using a Leica LS1200s
vibrating microtome in ice cold oxygenated artificial cerebrospinal fluid (aCSF) (120 mM NaCl, 3.5 mM KCl, 1.25 Mm NaH2PO4,
26 mMNaHCO3, 10 mMD-glucose, 1.3 mMMgSO4, 2.5 mMCaCl2, PH = 7.4, 290-320mOsm). Slices were transferred to a chamber
and held at 32C for 1 hour and at room temperature for an additional hour. All recordings were performed at room temperature. Mice
were divided into three groups (Ctrl, GcKO with vehicle control, and GcKO with IL-1b-RA groups). IL-1b–RA was used at a concen-
tration of 200 mg/ml.
Schaffer collateral inputs to the CA1 region were stimulated with a bipolar tungsten electrode. Field excitatory postsynaptic po-
tentials (fEPSPs) were recorded from neurons within the CA1 dendritic layer by insertion of an electrode in the Schaffer collateral
pathway as the stimulating electrode. Based on the stimulus–response curve, a stimulation intensity that evoked a fEPSP within
30% of the maximum response was selected and recorded for 20 min to establish a baseline. LTP was then induced with a two-train
high-frequency stimulus (100 Hz-30 s interval). The field potential response following tetanic stimulation was recorded for 60min. The
LTP magnitude was quantified as the percentage change in the average fEPSP slope over 60 min after LTP induction.
MEN1 coding regions sequencing
Genomic DNA used for analysis was extracted from peripheral white blood cells using standard phenol-chloroform extraction
methods. Coding exons of theMEN1 gene were confirmed using NCBI and Ensemble websites.MEN1 coding exons were amplified
by PCR, and the PCR products were bi-directionally characterized by Sanger sequencing (Sino GenoMax Company, Beijing, China).
Primers were designed using NCBI BLAST, and synthesized by Idobio Biological Technology (Beijing, China).
Behavioral Studies
Forced Swimming Test
The forced swim test (FST) was used to assess depressive-like behavior. Mice were placed in a container filled with water that even-
tually resulted in immobility, reflecting behavioral despair. Water (23 ± 1C) was placed in a transparent acrylic cylinder bath (10cm in
diameter, 20cm in height) filled to a depth of 13cm. Mice were placed in the water for six minutes using a video tracking system
(Smart 3.0); immobility duration (%) within the final 5 min of testing was recorded.
Tail Suspension Test
Mice were suspended by their tails from an acrylic bar (15cm in diameter, 30cm in height) for six minutes andmonitored using a video
tracking system (Smart 3.0). Escape-related behavior was assessed, where immobility duration (%) during the 6 min suspension
period was recorded.
Social Interaction
The test apparatus for social interaction comprised three rectangular chambers (18 3 35 3 18 cm) divided by plexiglass walls with
openings (63 5 cm) which allowed animals to move between chambers. Both side chambers contained an empty transparent plex-
iglass holder (8 cm in diameter, 10 cm high), with small holes allowing snout contact. Thewidth of the holes were of a sufficiently small
size to prevent biting or aggressive interactions between the animals. A test mouse was first released into the central chamber and
was allowed to habituate for 5 min. An unfamiliar gender- and age-matched stranger mouse was then placed in one of the holders.
The location of the stranger mouse in either of the two holders (the social chamber) varied systematically between trials. The test
mouse was allowed to explore the apparatus for 10 min. At the end of the 10 min duration, a novel mouse was placed in the other
holder. The test mouse was allowed to explore the entire apparatus for 10min. Time spent in sniffing each holder was recorded using
a video camera.
Sucrose Preference Test (SPT) and Sucrose Consumption Test (SCT)
Animals were first trained to consume a 1% sucrose solution from two differing bottles (48 hours before the formal experiment).
Twenty-four hours later, the animals were allowed free access to 1% sucrose and water from two differing bottles. To avoid bottle
side preference, the two bottles were switched. The amounts in the two bottles weremeasured after 24 hours and sucrose preference
was calculated according to the following formula: Sucrose preferences (%) = sucrose consumption / (sucrose + water
consumption) 3 100%.
Rotarod Test
Mice were placed on a stationary rotarod (AccuRotor Rota Rod Tall Unit, 63-cm fall height, 30-mm diameter rotating dowel; Accus-
can, Columbus, OH). The dowel was then accelerated to 60 rpm/min, and the latency to fall (in seconds) was recorded. The proced-
ure was repeated over 4 consecutive trials, which was averaged to yield the daily latency to fall for eachmouse. If an animal fell off the
rotarod rapidly (e.g., due to inattention or slips), they were placed back on the rotarod for an additional trial, and the latency was not
included in the daily average. The entire procedure was repeated for 2 additional days for a total of 3 days. In addition to the average
latency across the 4 trials per day, the maximum latency to fall per day was also analyzed.
Open Field Test
To explore locomotion and spontaneous activity, we characterized mouse behavior as they freely explored an open-field plastic
chamber (40-cm width3 40-cm length3 30-cm height) using a video tracking system (Smart 3.0). Two month old mice were placed
in this arena for 10 min., and total distance and time spent in the center region (20cm 3 20cm) was recorded.Neuron 100, 1–13.e1–e7, November 7, 2018 e6
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The apparatus comprised two opposing open arms (50 3 10 cm) and two opposing closed arms with roofless gray walls (40 cm)
connected by a central square platform and positioned 50 cm above the ground. Mice were placed in the open arms facing an
open arm, and their behavior was tracked for 5 min with an overhead camera and Smart 3.0 software. Time spent in the open
arms (%) was reported.
Morris Water Maze
The water maze used in this study comprised a circular tank 120 cm in diameter with a platform filled with tap water at a temperature
of 22 ± 2C. Different shapes were posted along the walls of the tank, which served as spatial reference cues. A camera wasmounted
above the maze to record the swimming traces in the water maze. During the acquisition trials, the platform was submerged 1-2 cm
below the water surface, mice were place into themaze at one of four points (N, S, E,W) facing the wall of the tank. Mice were allowed
to search for a platform for 60 s. If a mouse failed to find the platform, it was guided to the platform andmaintained on the platform for
10 s. Four trials a daywere conductedwith an intermission of 1hminimumbetween trials. Escape latency indicative of spatial memory
acquisition, was recorded for each trial. On day 7, the platform was removed and a probe test was conducted. The percentage time
spent in each of the four quadrants and the number of target (platform) area crossings, mean speed, total distance was recorded.
RNA-Sequencing analysis
Primary astrocytes from control or GcKOmice were cultured as described in the main text. Isolated RNA was subsequently used for
RNA-seq analysis. cDNA library construction and sequencing was performed by the Beijing Genomics Institute using BGISEQ-500
platform. High-quality reads were aligned to the mouse reference genome using Bowtie2. Expression levels for each of the genes
were normalized to fragments per kilobase of exon model per million mapped reads (FPKM) using RNA-seq by Expectation
Maximization (RSEM). We identified DEGs (differential expressed genes) between samples and performed clustering analysis and
functional annotation. Genes with R 2-fold change and false discovery rates (FDR) of% 0.001 were considered to be statistically
significant. Pathways overrepresented by DEGs were annotated in the KEGG (Kyoto Encyclopedia of Genes and Genomes)
database.
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical analysis
All data presented are expressed as arithmetic mean ± SEM. All statistical analyses were performed using GraphPad Prism version
5.0. Null hypotheses were rejected at p values equal to or higher than 0.05. For statistical comparisons between two groups, we first
performed a Shapiro-Wilk normality test (Prism) to determine whether the data was likely normally distributed. For normally-distrib-
uted data, we used unpaired Student’s t tests to evaluate statistical significance of differences between the two groups. Statistically
significant differences between groupswere determined using one-way ANOVA. In evaluatingmultiple comparisons, Tukey’s correc-
tion method was used to adjust p values accordingly to lower the probability of type I errors.
All electrophysiological results were analyzed using Sigma Stat 4 statistical software. Statistical significancewas evaluated by one-
way ANOVA with Holm-Sidak pairwise tests. Values of p < 0.05 were considered to be statistically significant. DNASTAR Laser gene
software (version 7.1) was used to analyze Sanger sequencing data. Hardy–Weinberg equilibrium (HWE) for genotypic distributions of
all detected SNPs were examined using chi-square (X2) goodness-of-fit tests. The chi-square test was applied to analyze differences
in genotypic distribution between MDD patients and controls.
Description of sample size (n-number)
For behavior tests described in the study, the number of mice analyzed in each group are described in the respective Figure Legends
(Figures 1A, 1B, 2, and 4); the number of slices and mice used for electrophysiological recordings is defined. For other experiments
(Western Blotting, Immunofluorescence, Golgi stains, CO-IP, Luciferase assay and Electrophysiology), the definition of ‘‘n’’ in the
context of independent experimental repeats are described in respective Figure Legends. All statistical details, including the exact
value of n, what n represents, and which statistical test was performed, is described in the Figure Legends.
DATA AND SOFTWARE AVAILABILITY
The SRA accession number for RNA-seq data reported in this paper is SRA: SRP151969.e7 Neuron 100, 1–13.e1–e7, November 7, 2018
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Figure S1. Mouse menin levels are attenuated and IL-1 levels are elevated in the Nucleus 
accumbens after CUMS, related to Figure 1 and Figure 3.  
Male C57BL/6 mice were exposed to chronic unpredictable mild stress (CUMS). 
A. Men1 mRNA levels in the Nucleus accumbens of CUMS/Control mouse brain. n=6 experimental 
replicates/group. 
B. IL-1 mRNA levels in the Nucleus accumbens of CUMS/Control mouse brain. n=6 experimental 
replicates/group. 





















Figure S2. Menin expression in neurons, microglia, astrocytes, and oligodendrocyte progenitor cells 
(OPCs), and oligodendrocytes in GcKO and control mouse brain, related to Figure 1 and 2. 
(A) Primary neurons, astrocytes, microglia, OPCs and oligodendrocytes were cultured as described in 
Methods. Neurons were stained with MAP2 and DAPI; astrocytes were stained with GFAP and DAPI, 
Microglia were stained with Iba1 and DAPI; OPC were stained with PDGFR and DAPI; 
Oligodendrocytes were stained with CC1 (Anti-adenomatous polyposis coli-APC) and DAPI; as 
indicated in Red (Iba1: Green) and Blue respectively. Scale bar: 100um. Purity of primary neurons or 
astrocyte cultures were also provided respectively. 
(B-C) Menin levels were detected by western blotting (B) and Real-time PCR (C) in the indicated cell 
types (neurons, microglia, astrocyte, OPC and Oligodendrocyte). TuJ1, Iba1, GFAP and Oligo2 were 
used as cell-specific markers for neurons, microglia, astrocytes and oligodendrocytes respectively, 
GAPDH served as a loading control. Data represent mean±SEM, n=3 experimental replicates/group; 
**p<0.01, ***p<0.001, one-way ANOVA with Tukey’s post hoc test. 
(D) Double immunofluorescence staining of menin (green) with CC1 (Red) or PDGFR (red) in mouse 
cortex regions. Arrows indicate that menin is barely detectable in oligodendrocytes in vivo (Scale bar: 
100μm) 
(E) MBP (Myelin basic protein) staining in cortex (E1) and hippocampus (E2) of GcKO/control mice 





Figure S3. GFAP-Cre and Fgfr3-iCre(ER) mediated Men1 reduction in mice (GcKO and FcKO), 
related to Figure 2. 
(A) Body weight of GcKO and littermate Control mice (control：n=20 mice；GcKO: n=12 mice). 
(B) Brain weight of one-month old GcKO and littermate control mice. 
(C) Kaplan-Meier survival curves from GcKO and control mice. (Control mice: n>50, GcKO mice: 
n>50). 
(D) Menin and PSD95 protein levels were significantly lower in cortex from GcKO mice compared to 
controls. n = 3 mice per group. 
(E-F) Double immunofluorescence staining of menin (green) with GFAP (E) or NeuN (F) reveal 
reductions in menin expression in astrocytes in GcKO mouse cortex. (Scale bar: 20μm). Astrocyte and 
neuron numbers were also quantified and presented in the adjacent panels (right). n > 100 cells from 6 
slices from 3 mice respectively. 
(G) Brain sections from postnatal three-month GcKO and Control mice were subjected to Nissl staining. 
Layer I, Layer II-V, and Layer VI measurements were quantified by Image J. Scale bar: 100μm, 20μm, 
20μm respectively.  
(H-J) Tamoxifen-induced menin reduction in FcKO mice; (H) Menin protein levels were significantly 
reduced in tamoxifen-treated FcKO mouse cortex compared to controls. n=3 mice per group. (I) Double 
immunofluorescence staining to detect menin (green) and GFAP (red) in tamoxifen-treated FcKO and 
control mouse cortex; menin expression is markedly reduced in astrocytes in FcKO mouse cortex (Scale 
bar: 20μm). Astrocyte numbers was also quantified and presented in the panels on the righthand side. n > 
100 cells from 6 slices from3 mice respectively. 
(J) No significant difference in brain weight was observed between 1 month old FcKO and control mice. 
(Control： n=11 mice；FcKO: n=10 mice)  
Data represent mean±SEM, n.s.: not significant, *p<0.05, ***p<0.001, A, unpaired t test，B-J, one-way 









Figure S4. Behavioral tests in GcKO and control mice, related to Figure 2. 
(A) GcKO and control mice behavior in Rotarod tests. 
(B) GcKO and control mice behavior in Open field tests. 
(C) GcKO and control mice behavior in High plus maze tests. 
(D-E) GcKO and control mice behavior in Morris Water Maze test.  
(Control: n=15mice；GcKO: n=12 mice) Data represent mean±SEM, n.s.: not significant,*p<0.05, 












Figure S5. Iba1 staining in the mPFC region of control and GcKO mice treated with IL-1-RA, 
related to Figure 3 and Figure 5. 
(A) GcKO and control mice brain slices were subjected to Iba1 (red) and DAPI (blue) staining. Scale 
bar: 20μm, 5μm respectively.  
(B) Characterizing Iba1-positive cells number, morphological parameters include cell body size and total 
processes length in microglia. At least 20 cells each from three mice were selected to quantify the 
morphological parameters. (n > 20 cells from 6 slices from 3 mice respectively)  
(C) Iba1 staining in the mPFC region of Control and GcKO mice treated with saline or IL-1-RA. Scale 
bar: 20μm, 5μm respectively.  
(D) Analyses of Iba1 positive cell number, size of cell body and total processes length in microglia. At 
least 20 cells each from three mice were selected to quantify the morphological parameters. (n > 20 
cells from 6 slices from 3 mice respectively) 
Data represent mean±SEM. n.s.: not significant, *p<0.05, **p<0.01, ***p<0.001, one-way ANOVA 



















Figure S6. p65 subcellular localization, IL-1 expression and NFB-mediated transactivation in 
CHG5 and HEK293 cells with LPS, related to Figure 3. 
(A) MEN1 and IL-1expression levels as determined by qRT-PCR in CHG5-MEN1 stable and control 
cells. Menin protein expression is shown in the lower panel. n=3 experimental replicates/group. 
(B) NFB-mediated transactivation in CHG5 cells with stable MEN1 overexpression compared to 
controls. n = 6/group/experiment. 
(C) IL-1 protein levels in CHG5 cells measured by ELISA. n=6 experimental replicates/group. 
(D) Menin expression in HEK293T cells transfected with GFP control, GFP-MEN1, scrambled siRNA, 
or shMEN1 siRNA. 
(E-F) NFB-mediated transactivation in HEK293T cells with menin overexpression (E) or knockdown 
(F). n=6 experimental replicates/group. 
(G) HEK293T cells were transfected with GFP and GFP-MEN1 plasmids, and subsequently treated 
with LPS as indicated. NFB-dependent transactivation was measured by Luciferase assay.  
(H) Menin and p65 protein levels in cytoplasmic and nuclear fractions from GcKO and control mouse 
brain cortex. Quantification of p65 levels are shown in the right panels, n=3 experimental 
replicates/group. 
(I) Menin and p65 protein levels in cytoplasmic and nuclear fractions from CHG-5 control vector (CHG-
5V) and CHG-5-MEN1 (CHG-5M) stably expressing cell lines. Quantification of p65 levels are shown 
in the right panels, n=3 experimental replicates/group. 
Data represent mean±SEM, n.s.: not significant, *p<0.05, **p<0.01, ***p<0.001, one-way ANOVA 









Figure S7. Synaptic proteins levels and IL-1 expression in GcKO and control mice treated with 
saline or IL-1-RA, related to Figure 5. 
Two-month old GcKO and littermate controls mice treated with an NF-B inhibitor (PDTC) or an IL-
1β-R-Antagonist (IL-1-RA) for 7 days. After behavioral analysis, cortex and hippocampus were 
processed for western blotting, ELISA and RT-PCR. Western blot analysis of protein expression in cortex 
(A-B) and hippocampus of GcKO (E-F) and control mice received saline or IL-1-RA. Immunoblots 
were probed with antibodies against the indicated proteins. n=4 experimental replicates/group. IL-1 
protein and mRNA levels were measured in cortex (C-D) and hippocampus (G-H) of GcKO and control 
mice treated with saline or IL-1-RA. n=4 experimental replicates/group.  















Figure S8. rs375804228 (G503D) does not alter transcription, protein expression, protein turnover, 
or cellular localization profiles in menin, related to Figure 6. 
 
(A-B) HEK293T cells transfected with a GFP control vector, or GFP-WT-MEN1, GFP-MEN1-G503D, 
GFP-MEN1-D418D, and GFP-MEN1-A541T were processed for mRNA (A) and protein (B) expression 
analysis by qRT-PCR/Western blotting. Quantitation is shown in the bottom panels. n = 6 experimental 
replicates/group.  
(C-D) HEK293T cells were transfected with GFP control vector, GFP-WT-MEN1, GFP-MEN1(G503D), 
GFP-MEN1(D418D), and GFP-MEN1(A541T) constructs. Cells were exposed to cycloheximide for the 
time indicated, and menin degradation was determined by western blotting. Representative blots are 
shown in panel C; Quantification of menin protein turnover is shown in D. Menin levels were 
standardized to GAPDH and normalized to time 0 (set to 100%). n=3 experimental replicates/group.  
(E) Menin and p65 localization was determined by GFP and p65 co-staining in HEK293T cells 
transfected with GFP, GFP-MEN1(WT), GFP-MEN1(D418D), GFP-MEN1(G503D) and GFP-
MEN1(A541T) plasmids. (Scale bar: 20μm). 
(F) p65 protein levels in HEK293T cytoplasmic and nuclear fractions in cells transfected with GFP, GFP-
MEN1 or GFP-MEN1(G503D) as determined by western blotting. Quantification of band intensities are 
presented on right panel, n=3 experimental replicates/group. 
Data represent mean±SEM. n.s.: not significant,***p<0.01, one-way ANOVA with Turkey post hoc test. 
 
